Craig A Collard Exercises Options at Heron Therapeutics Inc DE (HRTX) — SEC Form 4, Nov 03, 2026
SEC Form 4 · No Market Transaction
Option Exercise
Derivative exercise — no open market transaction.
Equity Position
940K sh
875,400 → 939,557
Equity Change
+7.3%
shares held after vs before
Filing Lag
2 business days
within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Reporting Owner
| Name | Relationship |
|---|---|
| Craig A Collard CIK 0001363558 |
Director
CEO
|
Craig A Collard at Heron Therapeutics Inc DE
Full insider history
Bought (12 mo)
—
Sold (12 mo)
—
More from this insider at Heron Therapeutics Inc DE
| 2026-10-21 | Exercise | — | View |
| 2026-08-03 | Exercise | — | View |
| 2026-07-20 | Exercise | — | View |
| 2026-05-04 | Exercise | — | View |
| 2026-04-21 | Exercise | — | View |
Non-Derivative Securities Transactions
| Title | Date | Type | Shares | Price | Net Total | Post-Txn | Ownership |
|---|---|---|---|---|---|---|---|
| Common StockF1 | 2026-10-30 | M - Exercise | 50,021 A | — | 916,950 | Direct | |
| Common Stock | 2026-10-30 | F - Tax Payment | 12,181 D | $0.28 | -$3,411 | 904,769 | Direct |
| Common StockF1 | 2026-10-31 | M - Exercise | 34,788 A | — | 939,557 | Direct | |
| Common Stock | 2026-10-31 | F - Tax Payment | 8,471 D | $0.28 | -$2,372 | 931,086 | Direct |
Derivative Securities Transactions
Footnotes (3)
- F1
- Each restricted stock unit represents a contingent right to receive one share of common stock. Show more
- F2
- On January 30, 2026 (the "Date of Grant"), the Reporting Person was granted 800,337 RSUs which vest upon the following time-based vesting schedule: the RSUs vest in 16 equal quarterly installments beginning one quarter after the Date of Grant. The full amount of the RSUs granted to the Reporting Person is reflected herein. Show more
- F3
- The restricted stock units vest in 16 equal installments beginning one quarter after the date of grant (January 31, 2025). Show more
Related filings at Heron Therapeutics Inc DE
Institutional Holders
13F holders · Jun 30, 2026
164
institutional managers reporting a position
Largest by reported value
- Rubric Capital Management Lp $12.8M
- Clearline Capital Lp $4.86M
- Black Rock, Inc. $4.5M
5%+ Holders · 13D/G
2 filers
-
Clearline Capital Lp 6.7%
Other insiders at Heron Therapeutics Inc DE
GET /v1/forms/4/0001193125-26-444851
API docs
View Original SEC Filing